Get the Stockscreener App
2.09
3.24%
-0.07
Invo Fertility Inc stock is traded at $2.09, with a volume of 356.00K.
It is down -3.24% in the last 24 hours and up +0.00% over the past month.
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body.
See More
Previous Close:
$2.16
Open:
$2.24
24h Volume:
356.00K
Relative Volume:
0.18
Market Cap:
$1.92M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+16.11%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$2.0802
$2.27
1-Week Range:
$1.86
$3.00
52-Week Range:
$1.65
$3.20
Invo Fertility Inc Stock (IVF) Company Profile
Name
Invo Fertility Inc
Sector
Industry
Phone
(978) 878-9505
Address
5582 BROADCAST COURT, SARASOTA
Compare IVF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IVF
Invo Fertility Inc
|
2.09 | 1.92M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Invo Fertility Inc Stock (IVF) Latest News
INVO Fertility, Inc.Common Stock (NQ: IVF - FinancialContent
INVO Fertility (IVF) Announces Record Revenues and Strategic Focus on Fertility Services - GuruFocus
Top Premarket Gainers - marketscreener.com
INVO Fertility Reports Strong Revenue Growth in 2024 - TipRanks
INVO Fertility Inc [IVF] Is Currently 48.45 above its 200 Period Moving Avg: What Does This Mean? - dbtnews.com
INVO Fertility Inc (NASDAQ: IVF) Has Succeeded In Gaining Momentum In 2025, The Stock Is Down -75.41% YTD - Marketing Sentinel
There is no way INVO Fertility Inc (IVF) can keep these numbers up - Sete News
INVO Fertility inks deal, issues new warrants By Investing.com - Investing.com Nigeria
INVO BioScience (IVF) Reports Q4 Revenue Growth - GuruFocus
INVO Fertility Inc reports results for the quarter ended December 31Earnings Summary - TradingView
INVO Fertility Stock Is Surging Wednesday: What's Going On? - Benzinga
Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher - Benzinga
INVO Fertility Announces 2024 Financial Results with 116% Annual - GuruFocus
INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA - The Manila Times
INVO Fertility, Inc. Reports Record Revenue Growth in Q4 2024 and Full Year 2024 Financial Results - Nasdaq
INVO Fertility, Inc. SEC 10-K Report - TradingView
INVO Fertility, Inc. will Change its Ticker to IVF from NAYA - marketscreener.com
Sarasota fertility company changes name, ticker symbol - Business Observer
INVO Fertility (IVF) to Begin Trading Under New Ticker Symbol | NAYA Stock News - GuruFocus
INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF” | NAY - GuruFocus
INVO Fertility To Begin Trading Under New Nasdaq Ticker Symbol 'IVF' - Nasdaq
INVO Fertility faces Nasdaq delisting over late 10-K filing - Investing.com
NAYA Biosciences to separate fertility and oncology businesses into distinct operations, changes name to INVO Fertility - Seeking Alpha
NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.” - GlobeNewswire
Free Registration Is Now Open For Tribe Public's CEO and Q&A Presentation Webinar Event "Accelerating Biotech Value Creation" Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday, October 31, 2023 - Seeking Alpha
NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025 - GlobeNewswire
NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment - GlobeNewswire
NAYA Biosciences Announces Nomination of New Board Members - GlobeNewswire
NAYA Biosciences Announces Pricing of $9.5 Million Public Offering - GlobeNewswire
NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody - GlobeNewswire
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - GlobeNewswire
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma - GlobeNewswire
NAYANAYA Biosciences Latest Stock News & Market Updates - Stock Titan
INVO Bioscience changes name, trading symbol after merger - Business Observer
Sarasota fertility company completes merger with bioscience firm - Business Observer
INVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - marketscreener.com
Naya Biosciences - The Pharma Letter
Lakewood Ranch fertility company posts 2023 results, stock trading soars - Business Observer
NAYA buys Florida Biotechnologies for $20M to get hold of rare genetic disease drug - Fierce Biotech
NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal - BioSpace
NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies - PR Newswire
NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger - PR Newswire
INVO to acquire NAYA to establish life science company - Pharmaceutical Technology
INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company - PR Newswire
INVO Closes Acquisition of Wisconsin Fertility Institute - PR Newswire
INVO Bioscience’s INVOcell Device Receives FDA Approval for 5-Day Incubation in Fertility Treatment - Femtech Insider
INVO Congratulates Wisconsin Fertility Institute on Being Named One of America's Best Fertility Clinics by Newsweek - PR Newswire
INVO Bioscience introduces next-gen technologies to fertility market in Taiwan - BioSpectrum Asia
INVO Bioscience Highlights INVOcell Progress From the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo - Seeking Alpha
Dr. Sue Ellen Carpenter of INVO Bioscience's Atlanta-based INVO CenterBloom FertilityNamed Top Doctor by Castle Connolly - PR Newswire
New Birmingham INVO Center Offers Families an Affordable Advanced Fertility Treatment Solution to Help Combat Rising Costs - PR Newswire
Invo Fertility Inc Stock (IVF) Financials Data
There is no financial data for Invo Fertility Inc (IVF). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):